Cognitive effects of paroxetine in older depressed patients

Journal of Clinical Psychiatry

Volumn 60, Issue SUPPL. 20, 1999, Pages 26-29

  Nebes, Robert D ^a,b   Pollock, Bruce G ^a   Mulsant, Benoit H ^a   Butters, Meryl A ^a   Zmuda, Michelle D ^a   Reynolds III, Charles F ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NORTRIPTYLINE; PAROXETINE;

ADULT; AGED; AGING; ANTICHOLINERGIC EFFECT; ARTICLE; ATTENTION; CLINICAL ARTICLE; COGNITION; DEMENTIA; DEPRESSION; DRUG BLOOD LEVEL; DRUG EFFECT; HUMAN; LEARNING; PRIORITY JOURNAL; TASK PERFORMANCE;

AGE FACTORS; AGED; AGED, 80 AND OVER; AMBULATORY CARE; ANALYSIS OF VARIANCE; COGNITION; COGNITION DISORDERS; DEPRESSIVE DISORDER; HOSPITALIZATION; HUMANS; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PAROXETINE; SEROTONIN UPTAKE INHIBITORS; WECHSLER SCALES;

EID: 0032861401     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Knegtering H, Eijck M, Huijsman A. Effects of antidepressants on cognitive functioning of elderly patients: a review. Drugs Aging 1994;5:192-199
2. Meyers BS, Mattis S, Gabriele M, et al. Effects of nortriptyline on memory self-assessment and performance in recovered elderly depressives. Psychopharmacol Bull 1991;27:295-299
3. Young RC, Mattis S, Alexopoulos GS, et al. Verbal memory and plasma drug concentrations in elderly depressives treated with nortriptyline. Psychopharmacol Bull 1991;27:291-294
4. Richelson E. Synaptic effects of antidepressants. J Clin Psychopharmacol 1996;16(2, suppl):1S-9S
5. Pollock BG, Mulsant BH, Nebes R, et al. Serum anticholinergicity in older patients treated with paroxetine or nortriptyline. Am J Psychiatry 1998; 155:1110-1112
6. Tune L, Coyle JT. Serum levels of anticholinergic drugs in the treatment of acute extrapyramidal side effects. Arch Gen Psychiatry 1980;37:293-297
7. Flicker C, Ferris SH, Serby M. Hypersensitivity to scopolamine in the elderly. Psychopharmacology (Berl) 1992;107:437-441
8. Nebes RD, Pollock BG, Mulsant BH, et al. Low-level serum anticholinergicity as a source of baseline cognitive heterogeneity in geriatric depressed patients. Psychopharmacol Bull 1997;33:715-719
9. Geretsegger C, Bohmer F, Ludwig M. Paroxetine in the elderly depressed patient: randomized comparison with fluoxetine of efficacy, cognitive and behavioral effects. Int Clin Psychopharmacol 1994;9:25-29
10. Schone W, Ludwig M. A double-blind study of paroxetine compared with fluoxetine in geriatric patients with major depression. J Clin Psychopharmacol 1993;13(2, suppl):34S-39S
11. Mulsant BH, Sweet RA, Rifai AH, et al. The use of the Hamilton Rating Scale for Depression in elderly patients with cognitive impairment and physical illness. Am J Geriatr Psychiatry 1994;2:220-229
12. Folstein MF, Folstein SE, McHugh PR. Mini-Mental State: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-198
13. Mattis S. Mental status examination for organic mental syndrome in the elderly patients. In: Bellack L, Karasu TB, eds. Geriatric Psychiatry. New York, NY: Grune and Stratton; 1976:77-121
14. First MB, Spitzer RL, Gibbon M, et al. Structured Clinical Interview for DSM-IV Axis I Disorders - Patient Edition (SCID-I/P, version 2.0). New York, NY: Biometric Research Department, New York State Psychiatric Institute; 1994
15. Hamilton M. Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol 1967;6:278-296
16. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition. Washington, DC: American Psychiatric Association; 1994
17. Shay KA, Duke LW, Conboy T, et al. The clinical validity of the Mattis dementia rating scale in staging Alzheimer's disease. J Geriatr Psychiatr Neurol 1991;4:18-25
18. Mulsant BH, Pollock BG, Nebes R, et al. A randomized double-blind comparison of nortriptyline and paroxetine in older depressed patients. Presented at the Annual Meeting and Symposium of the American Association of Geriatric Pharmacy; March 8-11, 1998; San Diego, Calif
19. Wechsler D. Wechsler Adult Intelligence Scale-Revised. San Antonio, Tex: Psychological Corp; 1981
20. Salthouse TA. What do adult age differences in the Digit Symbol Substitution Test reflect? J Gerontol 1992;47:P121-P128
21. Storandt M. Speed and coding effects in relation to age and ability level. Dev Psychol 1976;12:177-178
22. SAS Institute Inc. SAS/STAT: Software: changes and enhancements through release 6.11. Cary, NC: SAS Institute; 1997
23. Sunderland T, Tariot PH, Cohen RM, et al. Anticholinergic sensitivity in patients with dementia of the Alzheimer type and age-matched controls. Arch Gen Psychiatry 1987;44:418-426
24. Fairweather DB, Kerr JS, Harrison DA, et al. A double blind comparison of the effects of fluoxetine and amitriptyline on cognitive function in elderly depressed patients. Hum Psychopharmacol 1993;8:41-47
25. Georgotas A, McCue RE, Reisberg B, et al. The effects of mood charges and antidepressants on the cognitive capacity of elderly depressed patients. Int Psychogeriatrics 1989;1:135-143
26. Teri L, Reifler BV, Veith RC, et al. Imipramine in the treatment of depressed Alzheimer's patients: impact on cognition. J Gerontol 1991;46: P372-P377